Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company dedicated to developing innovative therapies for serious diseases through a unique approach to complement medicine. The company aims to improve the lives of patients facing significant health challenges, with a focus on unmet medical needs in conditions such as geographic atrophy, a leading cause of blindness. Apellis has successfully introduced two approved medicines targeting the complement component C3 and continues to expand its pipeline with nearly a dozen additional clinical and pre-clinical programs. The organization values collaboration, excellence, and compassion, and is committed to fostering a supportive environment where scientific inquiry and teamwork drive the development of life-changing treatments. Apellis is an equal opportunity employer and encourages a diverse workforce to support its mission.